Accumetrics’s VerifyNow system is a platform for measuring an individual’s response to multiple antiplatelet agents.
The distribution agreement marks the beginning of several new distribution channels for the company as it expands its reach both in scope and geography, said Accumetrics.
ELITech UK will concentrate its efforts on reaching customers in surgery suites and catheterization labs within UK hospitals and other medical centers.
Timothy Still, president and CEO of Accumetrics, said: “We are very pleased to have ELITech UK become our exclusive UK distributor. Their demonstrated expertise in this market and knowledge of our customer base in the UK will help expedite physician access to our products.
“This partnership marks the beginning of our distribution channel expansion outside the US and demonstrates our focus on rapidly growing our global presence.”